RELMADA THERAPEUTICS, INC.
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
RLMD | NDAQ
Overview
Corporate Details
- ISIN(s):
- US75954H1005 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 2222 PONCE DE LEON BLVD. 3RD FLOOR, 33134 CORAL GABLES
- Website:
- https://www.relmada.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative and novel treatments for debilitating disorders. The company's primary research area is central nervous system (CNS) diseases, with a significant focus on therapies for major depressive disorder (MDD), including its lead candidate esmethadone. Relmada is also advancing its development pipeline into oncology, with programs such as NDV-01 for urologic cancers. The company's mission is to create transformative medicines that improve human health.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
Automate Your Workflow. Get a real-time feed of all RELMADA THERAPEUTICS, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for RELMADA THERAPEUTICS, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for RELMADA THERAPEUTICS, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
%20Co.%2C%20Ltd/other/SLSBioSpecialty_Lab_Solution_Bio_Co._Ltd-logo.jpg){kind=logo}
